C

Citius Pharmaceuticals

D
CTXR
USD
0.0333
(9.471%)
Market Closed
45,540.00
Volume
-0.23
EPS
-
Div Yield
-1.603750
P/E
69,561,209.15
Market Cap
Today
9.4710%
1 Week
3.190%
1 Month
-2.186%
6 Months
-44.006%
12 Months
-50.084%
Year To Date
-49.289%
All Time
0%

Title:
Citius Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for thetreatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.
Do you need help or have a question?